These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 8706359

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T, Chantaphakul N, Thanwandee T, Ong-Ajyooth L.
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [Abstract] [Full Text] [Related]

  • 4. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH, Yilmaz ME, Suner A, Kadiroglu AK, Isikoglu B.
    Vaccine; 2004 Sep 28; 22(29-30):3963-7. PubMed ID: 15364445
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H, Dooki MR, Ebrahimnejad MS.
    J Med Assoc Thai; 2006 Oct 28; 89(10):1648-53. PubMed ID: 17128839
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F, Dixit V, Messa P, Martin P.
    Vaccine; 2012 Mar 16; 30(13):2295-300. PubMed ID: 22285268
    [Abstract] [Full Text] [Related]

  • 10. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG, Schiff M, Graves B, Agosti J, Barritt ML, Garner D, Holley JL.
    Clin Nephrol; 2000 Aug 16; 54(2):138-42. PubMed ID: 10968690
    [Abstract] [Full Text] [Related]

  • 11. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO, Resende MR, Oliveira AM, Sinkoc VM, Garcia MT, Angerami RN, da Silva LJ.
    Aliment Pharmacol Ther; 2007 Apr 01; 25(7):849-55. PubMed ID: 17373924
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD, Mashinter LD, Lindemulder A, Taylor GD, Chiu I.
    HIV Med; 2007 Jul 01; 8(5):295-9. PubMed ID: 17561875
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients.
    Navarro JF, Teruel JL, Mateos M, Ortuño J.
    Clin Nephrol; 1994 Feb 01; 41(2):113-6. PubMed ID: 8004827
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.